Expert in PK/PD and clinical pharmacology;Nearly 15 years of experience in preclinical research and clinical development of large and small molecule drugs in a multinational pharmaceutical company (Lilly USA)；Experienced in model-based drug development, especially in process optimization of drug screening, clinical dose level/dose frequency selection, early clinical trial design and data interpretation；Extensive experience in clinical and marketing registration (pre-IND, IND, EOP1, EOP2, pre-BLA, BLA, etc.)；Ph.D. from Ohio State University, M.S. from China Pharmaceutical University, B.S.from Peking University.